Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha

被引:296
|
作者
Zhang, B [1 ]
Berger, J [1 ]
Hu, EI [1 ]
Szalkowski, D [1 ]
WhiteCarrington, S [1 ]
Spiegelman, BM [1 ]
Moller, DE [1 ]
机构
[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02215 USA
关键词
D O I
10.1210/me.10.11.1457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies indicate that a peroxisome proliferator-activated receptor, PPAR gamma, functions as an important adipocyte determination factor. In contrast, tumor necrosis factor-alpha (TNF alpha) inhibits adipogenesis, causes dedifferentiation of mature adipocytes, and reduces the expression of several adipocyte-specific genes. Here, we report that treatment of 3T3-L1 adipocytes with TNF alpha resulted in a time- and concentration-dependent decrease in PPAR gamma mRNA expression to the level detected in preadipocytes. PPAR gamma mRNA levels were reduced by 95% with 3 nM TNF alpha treatment for 24 h. Half-maximal effects were seen after 3 h treatment with 3 nM TNF alpha or with 50 pM TNF alpha (24-h exposure). Parallel reductions in PPAR gamma protein levels were also observed after treatment of 3T3-L1 adipocytes with TNF alpha. Using a ribonuclease protection assay, both alternatively spliced PPAR gamma isoforms (gamma 1 and gamma 2) were shown to be negatively regulated by TNF alpha. The down-regulation of PPAR gamma by TNF-alpha preceded the diminution in expression of other adipocyte-specific genes including CCAAT/enhancer binding protein and adipocyte fatty acid-binding protein (aP2). The effect of TNF alpha was specific for the gamma-isoform of PPARs, since the expression of PPAR delta mRNA was not affected by treatment with TNF alpha. Low revel constitutive expression of PPAR gamma in 3T3-L1 adipocytes (at levels approximate to 2- to 3-fold higher than in preadipocytes) partially blocked the inhibitory effect of TNF alpha on aP2 and adipsin expression. These findings support the following conclusions: 1) PPAR gamma expression is necessary for the maintenance of the adipocyte phenotype. 2) ppAR gamma, but not PPAR delta, expression is sufficient to attenuate TNF alpha-mediated effects on adipocyte phenotype. 3) Reduced PPAR gamma gene expression is likely to represent an important component of the mechanism by which TNF alpha exerts its antiadipogenic effects.
引用
收藏
页码:1457 / 1466
页数:10
相关论文
共 50 条
  • [1] Effects of Peroxisome Proliferator-Activated Receptor-gamma on the Production of Tumor Necrosis Factor-alpha in Stimulated Human Monocoytes
    Kwon, Eun-Young
    Park, Chulmin
    Kwon, Jae-Cheol
    Kim, Si-Hyun
    Park, Sun Hee
    Choi, Su-Mi
    Lee, Dong-Gun
    Yoo, Jin-Hong
    Choi, Jung-Hyun
    INFECTION AND CHEMOTHERAPY, 2010, 42 (05): : 291 - 295
  • [2] Tumor necrosis factor-alpha negatively regulates peroxisome proliferator-activated receptor gamma transactivation in human monocytes.
    Boyer, JF
    Balard, P
    Authier, H
    Galera, V
    Mazieres, B
    Cantagrel, A
    Pipy, B
    Constantin, A
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S41 - S42
  • [3] Peroxisome proliferator-activated receptor-gamma ligands: Thiazolidinediones
    Zingarelli, B
    SHOCK, 2004, 21 : 126 - 126
  • [4] REGULATION OF ADIPOCYTE GENE-EXPRESSION AND DIFFERENTIATION BY PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-GAMMA
    TONTONOZ, P
    HU, E
    SPIEGELMAN, BM
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 1995, 5 (05) : 571 - 576
  • [5] What are the effects of peroxisome proliferator-activated receptor agonists on adiponectin, tumor necrosis factor-alpha, and other cytokines in insulin resistance?
    Boyle, PJ
    CLINICAL CARDIOLOGY, 2004, 27 (07) : 11 - 16
  • [6] Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma
    Akihiko Takeuchi
    Norio Yamamoto
    Toshiharu Shirai
    Katsuhiro Hayashi
    Shinji Miwa
    Seiichi Munesue
    Yasuhiko Yamamoto
    Hiroyuki Tsuchiya
    BMC Cancer, 16
  • [7] Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms with the development of asthma
    Oh, Sun-Hee
    Park, Se-Min
    Lee, Yoo Hoon
    Cha, Ji Yeon
    Lee, Ji-Yeon
    Shin, Eun Kyong
    Park, Jong-Sook
    Park, Byeong-Lae
    Shin, Hyoung Doo
    Park, Choon-Sik
    RESPIRATORY MEDICINE, 2009, 103 (07) : 1020 - 1024
  • [8] Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma
    Takeuchi, Akihiko
    Yamamoto, Norio
    Shirai, Toshiharu
    Hayashi, Katsuhiro
    Miwa, Shinji
    Munesue, Seiichi
    Yamamoto, Yasuhiko
    Tsuchiya, Hiroyuki
    BMC CANCER, 2016, 16
  • [9] Peroxisome Proliferator-Activated Receptor-Gamma Expression in the Lung Tissue of Obese Rats
    Hwang, Su Jin
    Kim, Jung Ho
    Shim, Jae Won
    Kim, Duk Soo
    Jung, Hye Lim
    Park, Moon Soo
    Lee, Won Young
    Kim, Se-Yeon
    Shim, Jung Yeon
    YONSEI MEDICAL JOURNAL, 2011, 52 (03) : 495 - 501
  • [10] Role of Peroxisome Proliferator-Activated Receptor-gamma in Vascular Inflammation
    Ohshima, Kousei
    Mogi, Masaki
    Horiuchi, Andmasatsugu
    INTERNATIONAL JOURNAL OF VASCULAR MEDICINE, 2012, 2012